. Author manuscript; available in PMC: 2011 Jan 28.

Published in final edited form as: Int J Tuberc Lung Dis. 2010 Oct;14(10):1244–1251.

Table 2.

Baseline demographic and clinical characteristics of pediatric XDR-TB cases

	Case 1	Case 2	Case 3	Case 4
Age at XDR-TB diagnosis, years^*	7.5	7	7.5	6
Sex	Male	Male	Female	Female
Reason for initial admission	Kwashiorkor and cough	Kwashiorkor, cough and diarrhea	Cough and fever	Lymphadenopathy
TB history prior to admission (age at prior TB diagnosis, years)	Active PTB (5.5)	No	No	LTBI (3), scrofula (5)
Duration of drug-susceptible TB treatment prior to XDR-TB diagnosis, months^*	3	6	6	Data unavailable
Duration as in-patient prior to XDR-TB diagnosis, months^*	17	8.5	7.5	5
CD4 count at time of HAART initiation, cells/mm³ (% lymphocytes)	420 (13)	177 (9)	Data unavailable	406 (20)
Time on HAART prior to XDR-TB treatment initiation, months	16	0	9	6

Diagnosis is measured at the time the diagnostic sputum sample was sent.

XDR-TB = extensively drug-resistant tuberculosis; TB = tuberculosis; PTB = pulmonary TB; LTBI = latent TB infection; HAART = highly active antiretroviral therapy.